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that the ascertainment strategies employed in the col-
lection of cohorts of kindreds with complex disorders
may have a marked effect on the ability to detect a given
susceptibility locus (McCarthy et al. 1998).
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Primary Autosomal Recessive Microcephaly:
Homozygosity Mapping of MCPH4 to
Chromosome 15
To the Editor:
Microcephaly is a condition in which the head circum-
ference is smaller than !3 SD below the mean for age.
Syndromic microcephaly is found in a number of envi-
ronmental, chromosomal, or single-gene disorders.Non-
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Table 1
Phenotypic Data of the Microcephaly Kindred
Characteristics Proband
Affected
Sister
Affected
Brother
Affected
Brother
Age (years) 22 21 19 16
Height (cm) 157 152 156 157
Weight (kg) 35 44 39 36
Head circumference (cm) 44.5 47 48 45
Head circumference relative to mean for age (SD) !6 !5 !5 !6
Figure 1 Genetic map of chromosome 15 markers. Distances
are shown in centimorgans. The distance between markers ACTC and
D15S98 is 19 cM. The blackened bar indicates the MCPH4 candidate
region.
syndromic, isolated microcephaly is also etiologically
heterogeneous, and micrencephaly—that is, a general-
ized reduction of the brain mass causing a small skull
without craniosynostosis—appears as a distinct subtype
within this group. When micrencephaly is the only or
the leading pathological alteration, it is referred to as
“primary microcephaly,” or “microcephalia vera” (Ross
and Frias 1977; Baraitser 1997). Mental retardation
ranges frommoderate to severe in primarymicrocephaly,
although motor development may be normal during the
first years of life. Linear and ponderal growth is often
impaired, and, although the cause for this finding is not
clear, a deficiency of growth hormone (GH) has been
implicated in some cases (Dacou-Voutetakis et al. 1974).
When familial, primary microcephaly often appears to
be transmitted as an autosomal recessive disorder (MIM
251200) with a significant proportion of cases associated
with parental consanguinity and with an incidence of 1/
30,000–1/250,000 (Van den Bosch 1959, and references
therein). Microcephaly may not be present until late in
the third trimester of pregnancy, so prenatal diagnosis
is problematic (Tolmie et al. 1987). Genetic heteroge-
neity has long been suspected, on the basis of subtle
phenotypic differences among families (Cowie 1960).
Recently, a locus for primary microcephaly, MCPH1,
has been identified at 8p22-pter by homozygosity map-
ping (see below), and evidence for locus heterogeneity
has been shown (Jackson et al. 1998). MCPH2 is as-
cribed to 19q13 in the Human Gene Nomenclature Da-
tabase, in which the as-yet-unpublished locus MCPH3
has also been registered.
Homozygosity mapping in consanguineous families is
based on the assumption that a rare mutation is inherited
from a common ancestor via both parents, so that af-
fected siblings are homozygous by descent, for poly-
morphic markers close to the disease locus. Comparison
of genotypic data, both between and within subjects,
makes it a powerful strategy that needs only a few af-
fected individuals in order to map a recessive disorder
(Lander and Botstein 1987). We now report homozy-
gosity mapping of a new locus,MCPH4, to chromosome
15, in a newly ascertained family.
The propositus is a male 22 years of age who pre-
sented, at age 4 mo, with microcephaly and left crypt-
orchidism. He was a first child born after an uneventful
pregnancy and delivery to healthy young Moroccan par-
ents, who are first cousins once removed and who both
have normal head circumferences and an otherwise un-
remarkable family history. No craniosynostosis was pre-
sent in the patient, and the initial psychomotor devel-
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Figure 2 Haplotypes in the microcephaly kindred. Blackened
symbols represent affected individuals. The region of homozygosity is
boxed.
opment was normal. In early childhood, growth was at
the 3d centile for height and weight, and microcephaly
was !6 SD below the mean for age (41.5 cm at age 4.0
years). Mental retardation was noted. In late childhood,
IQmeasures were consistently ∼50. A brain computed-
tomography scan showed large cerebral ventricles and
no cerebral malformation or neuronal ectopia. A partial
deficiency of GH secretion was demonstrated by dy-
namic testing with insulin, glucagon, and GH-releasing
factor. Therapeutic GH supplementation at age 11–13
years produced no change in the growth curves. The
pubertal development was normal. The patient now has
a kind, collaborative, cheerful personality. A sister and
two younger brothers presented with an identical picture
of microcephaly and with height and weight growth at
approximately the 3d centile (table 1). Minor malfor-
mations were noted in the youngest boy (epicanthal
folds, single palmar creases, a left preauricular tag, and
myopia) but not in the sister and other brother. GH
treatment in the youngest brother, at age 4–7 years,
yielded no appreciable effect on growth. Results of kar-
yotypes of blood lymphocytes were normal. Extensive
metabolic workups gave normal results. The levels of
maternal blood glucose and phenylalaninemia were
strictly normal.
The parents and patients gave informed consent to the
genomic study, and DNAwas extracted from peripheral-
blood leukocytes. In a first analysis, we studied markers
from the 8p region, where MCPH1 maps (Jackson et al.
1998), and found no evidence for linkage. A genome-
wide screen was then launched by use of a set of mi-
crosatellite markers from the Cooperative Human
Linkage Center human screening set, Weber version 9
(Research Genetics). From this set of 386 markers, 239
(mainly tetranucleotides) were selected to span the entire
genome in intervals of 30 cM, since this spacing is
sufficient for detection of homozygosity by descent in a
family with this coefficient of inbreeding (Terwilliger et
al. 1997). A pooling approach was employed for the
initial screen. The DNAs of the parents were pooled in
one sample, and the DNAs of the affected children were
pooled in another (Arbour et al. 1997). Subsequently,
these pools were typed by PCR amplification using 6 ng
of each individual’s DNA in a 15-ml final volume, fol-
lowed by PAGE and silver staining (Budowle et al.
1988). Seven loci in the affected siblings—on 2q, 8p,
12p, 12q, 13q, and 15q—were identified as homozygous
by state. These loci were then analyzed in the individual
subjects, with additional, closely spaced markers (!2 cM
apart). Marker order was obtained from the Center for
Medical Genetics map, the Cooperative Human Linkage
Center map, GeneMap ’98, and the Genetic Location
Database. When minor discrepancies between the vari-
ous maps were observed, radiation-hybrid mapping was
performed to determine the most probable order, by use
of the GeneBridge 4 panel (Research Genetics) and the
RH mapping program of the Whitehead Institute for
Biomedical Research/MIT Center for Genome Research.
Six of the seven initial regions (listed above) were not
consistently homozygous at each polymorphic locus, in-
dicating, for the initial marker locus, identity by state
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Figure 3 Results of MAPMAKER/HOMOZ multipoint linkage
analysis. A maximum multipoint LOD score of 3.29 is observed at
CYP19.
rather than identity by descent. Conversely, one of the
seven markers initially identified on chromosome 15q
was found to be part of a genomic segment (fig. 1) where
all informative markers were homozygous in the affected
siblings but were heterozygous in the parents. This was
consistent with identity by descent and homozygosity
for a disease haplotype (fig. 2).
Multipoint linkage analysis was performed by use of
the MAPMAKER/HOMOZ algorithm software (Krug-
lyak et al. 1995), under the assumption of a fully pen-
etrant disease with an allele frequency of .002. Allele
frequencies for each polymorphic marker of the candi-
date region were evaluated by genotyping 30 unrelated
individuals from the same ethnic population. This anal-
ysis provided a maximum multipoint LOD score of 3.29
(fig. 3). Heterozygosity was found in one of the affected
siblings for marker ACTC and in all four affected sib-
lings for marker D15S98 (fig. 2), indicating that recom-
bination events had occurred at both loci. Thus, a min-
imal critical region—that is, the smallest region found
to be identical by descent, in all affected siblings—of 19
cM was observed between markers ACTC and D15S98.
Because of uninformativeness of parental markers for its
boundaries, however, the critical region might be as
small as 5.3 cM, encompassing D15S222 and D15S962.
Although linkage to this candidate region should be
confirmed in additional families, our results present
strong evidence for the presence of a new gene,MCPH4,
at15q15-q21, a mutation of which presumably affects
an aspect of neuronal proliferation. Although, during
the past few years, knowledge of neuronal migration and
brain-patterning defects such as holoprosencephaly or
schizencephaly has increased, the molecular defects of
neuronal proliferation are still poorly known. Consid-
ering the complexity of this process, locus heterogeneity
is not unexpected (Walsh 1999). Identifying the genes
implicated in primary microcephaly may prove partic-
ularly useful, since proper animal models for the devel-
opmental defects affecting the growth of the hemispheres
are lacking, in part because of its human-specific nature.
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Association of RET Protooncogene Codon 45
Polymorphism with Hirschsprung Disease
To the Editor:
The RET protooncogene (MIM 164761) is expressed in
human tissues of neural crest origin and has been rec-
ognized as a susceptibility gene for several autosomal
inherited diseases, such as Hirschsprung disease (HSCR
[MIM 142623]) and multiple endocrine neoplasia type
2 syndromes (MEN 2 [MIM 171400]) comprising med-
ullary thyroid carcinoma (MTC [MIM 155240]) as an
obligatory feature (Eng et al. 1997). Of the patients with
HSCR, 10%–40% have been reported to harbor germ-
line mutations of the RET protooncogene, which are
primarily point mutations scattered throughout the ex-
tracellular domain and within the intracellular tyrosine
kinase domain of RET (Edery et al. 1994b; Romeo et
al. 1994; Angrist et al. 1995; Seri et al. 1997). MEN 2
syndrome germline mutations of the RET protoonco-
gene have been found to affect exons 10, 11, and 13–16
(Donis-Keller et al. 1993; Mulligan et al. 1993; Carlson
et al. 1994; Eng et al. 1994; Hofstra et al. 1994; Bolino
et al. 1995). Functional studies have demonstrated that
RET mutations that characterize the autosomal domi-
nant–inherited MEN 2 cause activation of the RET-sig-
naling pathway, often in a constitutive manner or by
altering the substrate specificity (Borrello et al. 1995;
Santoro et al. 1995; Ceccherini et al. 1997; Pasini et al.
1997; Chappuis-Flament et al. 1998). In contrast, RET
mutations found in HSCR presumably result in either
RET-protein truncation or functional inactivation of the
molecule. Although loss of one allele in some patients
with HSCR suggests haploinsufficiency (Martucciello et
al. 1992), the retention of one wild-type allele in patients
with HSCR who have an inactivating RET mutation
seems to explain the presumed autosomal dominant in-
heritance and implicates a dominant-negative action of
the mutated RET allele (Badner et al. 1990; Cosma et
al. 1998).
Furthermore, several polymorphisms in the coding re-
gion of the RET protooncogene have been described. A
panel of the most frequent polymorphisms has been re-
ported by Mulligan et al. (1993), Ceccherini et al.
(1994), and Sa´ez et al. (1998), comprising those in co-
dons 45, 125, 432, 691, 769, 836, and 904. In the study
by Ceccherini et al., the allele frequencies of these poly-
morphisms were evaluated in a normal control group.
These data were confirmed by a study by Gimm et al.
(1999), and similar allele frequencies of the codon 45
polymorphism have been described by Edery et al.
(1994a), who focused on a control population only. All
of the investigated polymorphisms are silent mutations,
except for the codon 691 polymorphism, which results
in a change in the amino acid residue, from glycine to
serine. Bugalho et al. (1994) investigated the frequency
of the codon 691 polymorphism in a small population
of clinically defined sporadic medullary thyroid carci-
nomas (MTC) and found no significant differences from
a normal control population. Elsewhere, Gimm et al.
(1999) have investigated all seven RET polymorphisms
in a population with sporadic MTC and have found an
